APA

Christian S., Merz C., Evans L., Gradl S., Seidel H., Friberg A., Eheim A., Lejeune P., Brzezinka K., Zimmermann K., Ferrara S., Meyer H., Lesche R., Stoeckigt D., Bauser M., Haegebarth A., Sykes D. B., Scadden D. T., Losman J. & Janzer A. (20200203). The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies. : Leukemia.

Chicago

Christian Sven, Merz Claudia, Evans Laura, Gradl Stefan, Seidel Henrik, Friberg Anders, Eheim Ashley, Lejeune Pascale, Brzezinka Krzysztof, Zimmermann Katja, Ferrara Steven, Meyer Hanna, Lesche Ralf, Stoeckigt Detlef, Bauser Marcus, Haegebarth Andrea, Sykes David B, Scadden David T, Losman Julie-Aurore and Janzer Andreas. 20200203. The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies. : Leukemia.

Harvard

Christian S., Merz C., Evans L., Gradl S., Seidel H., Friberg A., Eheim A., Lejeune P., Brzezinka K., Zimmermann K., Ferrara S., Meyer H., Lesche R., Stoeckigt D., Bauser M., Haegebarth A., Sykes D. B., Scadden D. T., Losman J. and Janzer A. (20200203). The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies. : Leukemia.

MLA

Christian Sven, Merz Claudia, Evans Laura, Gradl Stefan, Seidel Henrik, Friberg Anders, Eheim Ashley, Lejeune Pascale, Brzezinka Krzysztof, Zimmermann Katja, Ferrara Steven, Meyer Hanna, Lesche Ralf, Stoeckigt Detlef, Bauser Marcus, Haegebarth Andrea, Sykes David B, Scadden David T, Losman Julie-Aurore and Janzer Andreas. The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies. : Leukemia. 20200203.